Koenig, Steven M <br/><br/>
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?  [electronic resource] 

 -  Respiratory medicine  May 2008 
 - 665-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-6111 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2007.12.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Albuterol--administration & dosage<br/>Androstadienes--administration & dosage<br/>Anti-Asthmatic Agents--administration & dosage<br/>Area Under Curve<br/>Asthma--drug therapy<br/>Bronchial Hyperreactivity--diagnosis<br/>Bronchoconstrictor Agents<br/>Bronchodilator Agents--administration & dosage<br/>Child<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Fluticasone<br/>Humans<br/>Latin America<br/>Latvia<br/>Male<br/>Metered Dose Inhalers<br/>Methacholine Chloride<br/>Middle Aged<br/>Patient Selection<br/>Practice Guidelines as Topic<br/>Salmeterol Xinafoate<br/>Treatment Outcome<br/>United States